Introduction about NASDAQ: ADMA
ADMA Biologics, Inc. is a biopharmaceutical
company that mainly deals with the marketing, manufacturing, and development of
some plasma-derived biologics. The company was mainly founded by Adam S.
Grossman and Jerrold B. Grossman. This company is headquartered in Hackensack,
NJ. This company is registered under Nasdaq with the name “adma”. Some
information about NASDAQ: ADMA at https://www.webull.com/quote/nasdaq-adma:
Top
reasons to invest in the pharmaceutical industry:
- The
pharmaceuticals sector has been the source of strong growth, in spite of
having the potentially high-risk category of the business. This industry
is mainly dependent on the research and development of some new products,
and patent protection. The industry has mainly experienced about 3 percent
annual growth rate since 2014. Some of the agencies are mainly projecting
the growth of 2 percent to 5 percent to exceed the revenue of $1.1
trillion in 2024.
- Today,
the biopharmaceutical company normally generates global revenues of $163
billion, which makes up about 20 percent of the pharma market. This is the
fastest-growing area of the pharma industry. The biopharma company’s
current annual growth rate is more than 8 percent which is double the
amount of the conventional pharma, and the growth rate is expected to
rise.
- The
efficacy and safety of biopharmaceutical products, which is mainly
combined with their ability to address some of the previously untreatable
conditions. The pharmaceutical
companies mainly develop products according to people's needs. These
companies produce some of the drugs which treat or prevent diseases and
the vaccines for immunization against bacterial and viral infections. They
continuously invest in the research and development to launch some new
drugs. The increase in the number of older people, many of whom need
prescription medicines, is an advantage to the healthcare sector,
particularly the pharma companies.
- There
is a very good scope for the long-term earnings. One can just sell the
same drugs in different markets. There is a lot of scope for the mergers
and acquisitions in the pharmaceutical sector.
Some
of the top facts to know about ADMA Biologics, Inc
This company was founded in the year 2004. As
far as the revenue growth is concerned, the ADMA's revenue has grown by 102.69%
over the past 12 months. This company has got a nice shareholders yield.
Shareholder’s yield means how much capital has been returned to the
stockholders through the dividends. Some of the similar stocks like ADMA are
TTMI, MNKD, and SWM.
One should study about the financial portfolio
of the company before investing. These biopharma companies are the key pillars
of many countries' economies. You can
find stocks
to invest in after
checking more stock news.
0 comments: